Experian Sees Revenue Growth at Higher End of Range
By Elena Vardon
Experian expects its revenue growth for fiscal 2024 at the higher end of its guided range, the credit-reporting agency said Tuesday.
The London-listed group said it now expects organic revenue growth to be between 5% and 6% at constant exchange for the year ending March 31, compared with previous guidance of between 4% and 6%. Analysts estimates point to 5.2% growth for the period, according to the latest company-compiled consensus.
For the three months ended Dec. 31, the company posted organic revenue growth of 6% and total revenue growth of 7%, both at constant-exchange rates.
"We delivered good growth in Q3, at the upper end of our expectations," Chief Executive Brian Cassin said.
Its North America business--which makes up more than two-thirds of its total revenue--reported organic revenue growth of 5%, while its Latin America segment--which brings in 15% of revenue--posted 13% growth. Its smaller U.K. and Ireland division reported 3% organic growth, while the Europe, Middle East, and Africa and Asia-Pacific division reported organic revenue growth of 7%.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
January 16, 2024 02:35 ET (07:35 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks